Platform Aeronaut
HomeLeaderboardCompaniesChartsBenchmarks
Profile

Platform Aeronaut SBC & Dilution

Quarterly dilution analytics, leaderboard rankings, and source-auditable methodology workflows.

Menu

  • Home
  • Leaderboard
  • Companies
  • Sectors

Legal

  • Methodology
  • Disclaimer
  • Privacy Policy
  • Terms of Use

Platform Aeronaut

  • Substack
  • Transcripts
  • AV Rideshare Economics

© 2026 Platform Aeronaut. All rights reserved.

Home/Internet/PDD
Pinduoduo logo

Pinduoduo (PDD)

Pinduoduo TTM Dilution

Pinduoduo Dilution Benchmarks

Blended DilutionWeighted TTM dilution combining the trailing, forward, and SBC methodologies.0.5%▼
0%
2.7%3Q25 0.5%
4%
Trailing DilutionTTM employee shares issued divided by shares outstanding.0.9%▼
0%
2.8%3Q25 0.9%
4%
Forward DilutionTTM net employee equity grants divided by shares outstanding.0.1%▼
0%
2.5%3Q25 0.2%
4%
SBC DilutionTTM stock-based compensation expense divided by average market capitalization.0.8%▼
0%
3.0%3Q25 0.7%
4%

Loading employee comparisons…

Pinduoduo Quarterly Metrics

Pinduoduo quarterly financial and dilution metrics. Dollar amounts in millions.
Fiscal QuarterRevenueFCFSBCSBC % of RevSBC % of FCFBlended DilutionTrailing DilutionForward DilutionSBC Dilution
3Q2616,1596,3752211.4%3%0.5%0.9%0.1%0.8%
2Q2616,5603,7421931.2%5%0.5%0.9%0.1%0.8%
1Q26Log in to view this quarter
4Q25Log in to view this quarter
3Q25Log in to view this quarter
2Q25Log in to view this quarter

Log in below to see every quarter back to 4Q19

Estimated financial inputs (36)
QuarterMetricEstimate / source
3Q26Free cash flowEstimated FCF: reported quarterly operating cash flow of $6,416,000,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Prior-year run-rate proxy; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q26Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
2Q26Free cash flowEstimated FCF: reported quarterly operating cash flow of $3,783,000,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Prior-year run-rate proxy; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Reported quarterly cash flow: mislabeled currency header resolved against the issuer’s disclosed RMB/USD rate, six translated cash-flow rows and both cash reconciliations. Filing 1

Prices and award values use USD per ordinary share; one traded ADS represents 4 ordinary shares. Source

Login Required

Authenticate with Platform Aeronaut to access this page. After clicking the magic link in email, return to this tab and refresh.

Filing 2
2Q26Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
1Q26Free cash flowEstimated FCF: reported quarterly operating cash flow of $2,384,000,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Prior-year run-rate proxy; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q26Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
4Q25Free cash flowEstimated FCF: reported quarterly operating cash flow of $3,449,049,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q25Free cash flowEstimated FCF: reported quarterly operating cash flow of $6,413,899,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q25Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
2Q25Free cash flowEstimated FCF: reported quarterly operating cash flow of $3,021,059,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
2Q25Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
1Q25Free cash flowEstimated FCF: reported quarterly operating cash flow of $2,138,292,000 less $40,936,000 allocated capex. Estimate: annual cash capex of $163,744,000 for 2025-01-01–2025-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q25Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
4Q24Free cash flowEstimated FCF: reported quarterly operating cash flow of $4,047,944,000 less $33,124,250 allocated capex. Estimate: annual cash capex of $132,497,000 for 2024-01-01–2024-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q24Free cash flowEstimated FCF: reported quarterly operating cash flow of $3,921,898,000 less $33,124,250 allocated capex. Estimate: annual cash capex of $132,497,000 for 2024-01-01–2024-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q24Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
2Q24Free cash flowEstimated FCF: reported quarterly operating cash flow of $6,026,068,000 less $33,124,250 allocated capex. Estimate: annual cash capex of $132,497,000 for 2024-01-01–2024-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
2Q24Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
1Q24Free cash flowEstimated FCF: reported quarterly operating cash flow of $2,917,771,000 less $33,124,250 allocated capex. Estimate: annual cash capex of $132,497,000 for 2024-01-01–2024-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q24Share denominatorEstimate: reported quarterly basic weighted-average ordinary shares used as a proxy for unavailable closing shares. This is an average, not a reported period-end count; actual closing shares take priority. Filing
4Q23Free cash flowEstimated FCF: reported quarterly operating cash flow of $5,195,942,000 less $20,559,500 allocated capex. Estimate: annual cash capex of $82,238,000 for 2023-01-01–2023-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q23Free cash flowEstimated FCF: reported quarterly operating cash flow of $4,459,684,000 less $20,559,500 allocated capex. Estimate: annual cash capex of $82,238,000 for 2023-01-01–2023-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
2Q23Free cash flowEstimated FCF: reported quarterly operating cash flow of $3,226,453,000 less $20,559,500 allocated capex. Estimate: annual cash capex of $82,238,000 for 2023-01-01–2023-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q23Free cash flowEstimated FCF: reported quarterly operating cash flow of $194,831,000 less $20,559,500 allocated capex. Estimate: annual cash capex of $82,238,000 for 2023-01-01–2023-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
4Q22Free cash flowEstimated FCF: reported quarterly operating cash flow of $3,849,426,000 less $23,042,500 allocated capex. Estimate: annual cash capex of $92,170,000 for 2022-01-01–2022-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q22Free cash flowEstimated FCF: reported quarterly operating cash flow of $1,637,990,000 less $23,042,500 allocated capex. Estimate: annual cash capex of $92,170,000 for 2022-01-01–2022-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
2Q22Free cash flowEstimated FCF: reported quarterly operating cash flow of $2,892,443,000 less $23,042,500 allocated capex. Estimate: annual cash capex of $92,170,000 for 2022-01-01–2022-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q22Free cash flowEstimated FCF: reported quarterly operating cash flow of $-1,430,457,000 less $23,042,500 allocated capex. Estimate: annual cash capex of $92,170,000 for 2022-01-01–2022-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
4Q21Free cash flowEstimated FCF: reported quarterly operating cash flow of $2,573,483,000 less $128,959,500 allocated capex. Estimate: annual cash capex of $515,838,000 for 2021-01-01–2021-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q21Free cash flowEstimated FCF: reported quarterly operating cash flow of $1,355,894,000 less $128,959,500 allocated capex. Estimate: annual cash capex of $515,838,000 for 2021-01-01–2021-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
2Q21Free cash flowEstimated FCF: reported quarterly operating cash flow of $1,141,655,000 less $128,959,500 allocated capex. Estimate: annual cash capex of $515,838,000 for 2021-01-01–2021-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q21Free cash flowEstimated FCF: reported quarterly operating cash flow of $-568,477,000 less $128,959,500 allocated capex. Estimate: annual cash capex of $515,838,000 for 2021-01-01–2021-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
3Q20Free cash flowEstimated FCF: reported quarterly operating cash flow of $1,225,667,000 less $1,649,250 allocated capex. Estimate: annual cash capex of $6,597,000 for 2020-01-01–2020-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
2Q20Free cash flowEstimated FCF: reported quarterly operating cash flow of $777,814,000 less $1,649,250 allocated capex. Estimate: annual cash capex of $6,597,000 for 2020-01-01–2020-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
1Q20Free cash flowEstimated FCF: reported quarterly operating cash flow of $-80,086,000 less $1,649,250 allocated capex. Estimate: annual cash capex of $6,597,000 for 2020-01-01–2020-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
4Q19Free cash flowEstimated FCF: reported quarterly operating cash flow of $1,378,668,000 less $985,250 allocated capex. Estimate: annual cash capex of $3,941,000 for 2019-01-01–2019-12-31 ÷4. Allocated within that fiscal year; quarterly timing is unknown. Actual quarterly cash capex takes priority. Includes the issuer’s combined cash purchases of property, equipment, software and intangible assets where reported; uses the annual filing’s USD translation. Filing 1Filing 2
Revenue / EmployeeTTM revenue divided by average headcount.$2.7M2.2× higher
SBC / EmployeeTTM stock-based compensation expense divided by average headcount.$36.2k1.4× lower
FCF / EmployeeTTM free cash flow divided by average headcount.$648.5k3.0× higher
$ Grant / EmployeeTTM net grant value divided by average headcount. Grant value uses net grant shares and average quarterly stock prices. Negative values reflect net award reductions.$5.6k9.8× lower